CClinicalTrials.gg
CompletedNCT02309814Updated Sep 8, 2016

Eyelid Movement Sensor Device- Blinking Characterizing

An interventional study of eyelid motion sensor device (Hall-probe) in Eyelid Movement Disorders, sponsored by HaEmek Medical Center, Israel. Completed. Open to participants aged 18 Years to 67 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2016-09-08.

Sponsored by HaEmek Medical Center, Israel · Not applicable, Interventional, and Basic science

Phase
Not applicable
Study type
Interventional
Enrollment
80
Allocation
Not applicable
Ages
18 Years to 67 Years
Sex
All
01

Study summary

The investigators have developed a simple to use device that facilitates the monitoring of the upper eyelids motion, acquires the eyelid vertical movement and enables analysis and graphic presentation of the results. the device system consists 3 components : glasses for the patient including magneto sensitive probes, hardware and dedicated software.

Our purpose is to characterize eyelid motion in normal population. The methods include measuring each patient 10 minutes during watching a short movie.

Read the detailed description

Essentially, for Hall-probes monitor the magnetic field generated by a tiny magnets attached to the upper eyelid.

02

Conditions studied

  • Eyelid Movement Disorders

Browse trials for

03

In context

Movement Disorders

320 studies on the registry are indexed under Movement Disorders; 98 are open to participants now.

This study's enrollment of 80 is above the median of 46 across 180 interventional studies indexed under Movement Disorders.

Browse Movement Disorders studies →

Lead sponsor

HaEmek Medical Center, Israel is the lead sponsor of 228 studies on the registry; 12 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 67 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • healthy 18-67 year olds with no eye medical history

Exclusion criteria

Exclusion Criteria:

  • pregnancy
  • head trauma history
  • using contact lens
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
80 participants (actual)

Study arms

  • Experimental
    eyelid motion sensor device

    all volunteers will wear the monitor eyelid sensor device (including the tiny magnets on the upper eyelid). a 10 minutes movie will be screened on 40 inch television screen in a 3 meters distance.

    Device: eyelid motion sensor device (Hall-probe)

Interventions

  • Deviceeyelid motion sensor device (Hall-probe)

    all volunteers will wear the eyelid motion sensor device (Hall-probe) (including the tiny magnets on the upper eyelid). a 10 minutes movie will be screened on 40 inch television screen in a 3 meters distance

06

What researchers measure

Primary outcomes

  1. Demonstrate and describe measurable blinking character in normal population.(Hall-probes monitor the magnetic field generated by a tiny magnets attached to the upper eyelid)

    Time frame: 10 minutes

07

Study locations

No study locations are listed for this record.

08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 8, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02309814
Lead sponsor
HaEmek Medical Center, Israel
Responsible party
daniel briscoe (Head of ophthalmology departement, HaEmek Medical Center, Israel) — Principal investigator
First posted
Dec 5, 2014
Start date
Jan 2015
Primary completion
Aug 2016
Completion
Aug 2016
Last update
Sep 8, 2016

Study contacts

daniel briscoe
principal investigator · haemek medical center

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion